IBD-associated CRC: different features, worse prognosis?
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Clinical features of colorectal cancer (CRC) in patients with IBD differ significantly from those without IBD, and may be associated with increased mortality.
Why this matters
- IBD-associated CRC and sporadic CRC appear to be different clinical entities with potentially different prognoses.
- Of 12,578 patients newly diagnosed with CRC, 101 (0.8%) had a history of IBD (61 ulcerative colitis and 40 Crohn's disease).
- Mean age at CRC diagnosis was increased for patients without vs with IBD (67.1 vs 52.8 y; P<.001).
- Compared with those without IBD, patients with IBD-associated CRC were more likely to be men (OR, 1.90), aged <65 y (OR, 6.77), and have CRC in the proximal colon (OR, 2.79).
- After adjusting for age, sex, and stage at diagnosis, IBD-associated CRC had increased mortality risk (HR, 1...65>